Nephron Pharmaceuticals Investing $313 Million in SC Expansion Expected to Create 707 Jobs
10/28/2011
Nephron is a global leader in manufacturing generic respiratory medications available to retail pharmacies, hospitals, home care companies and other customers. Its Orlando, Florida-based headquarters is comprised of 250,000-sq.-ft. of manufacturing, distribution and packaging facilities. The company has distribution centers in Kentucky and Arizona.
"We are excited to expand our company by locating our new manufacturing facility in Lexington County" said CEO Lou Kennedy. "This is a big step for our firm and will help us meet increased demand, expand our market share and develop our pipeline of products. South Carolina has an excellent business environment and we look forward to our expansion into the Palmetto State."
The South Carolina Dept. of Commerce has committed a set-aside grant of $4.5 million for site preparation and infrastructure. Nephron also was approved for job development credits, available when hiring targets are met. In addition, it will receive training support from the state's ReadySC program.
Project Announcements
Interstate Group Expands Giles County, Virginia, Production Operations
03/11/2026
Shinhwa Auto USA Expands Auburn, Alabama, Operations
03/11/2026
General Atomics Expands Shannon, Mississippi, Production Operations
03/11/2026
Starbucks Plans Davidson County, Tennessee, Corporate Operations
03/08/2026
Canada-Based Dainty Foods Plans Batavia Township, Ohio, Manufacturing Operations
03/08/2026
AeroVironment Expands Albuquerque, New Mexico, Manufacturing Operations
03/08/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
Economic Developer Role Shifting from Deal-Making to Systems Stewardship
Q1 2026
-
The New Industrial Revolution in Biotech
Q4 2025
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
The Skilled Trades Are Ready for a Digital Future
Q4 2025